Clinical trials
Recruiting Phase 2 Myelodysplastic Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 2 |
| 2014 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 7 |
| 2024 | 16 |
| 2025 | 20 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 74 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 9 |
| City of Hope Medical Center | 4 |
| Fred Hutchinson Cancer Center | 4 |
| St. Petersburg State Pavlov Medical University | 4 |
| Masonic Cancer Center, University of Minnesota | 3 |
| National Cancer Institute (NCI) | 3 |
| Peking University People's Hospital | 3 |
| Beijing 302 Hospital | 2 |
| Mayo Clinic | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 74 |
| Leukemia, Myeloid, Acute | 39 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 18 |
| Myeloproliferative Disorders | 16 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 13 |
| Leukemia, Myelomonocytic, Chronic | 13 |
| Leukemia, Biphenotypic, Acute | 11 |
| Lymphoma, Non-Hodgkin | 11 |
| Hodgkin Disease | 10 |
| Graft vs Host Disease | 6 |
Trials
Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.